Physician profile
Brendan Thomas Eby
NPI 1184030991
$27,111.36
in general payments reported to CMS, 2019-2025
11 companies · $16K in 2025
The $16K reported for 2025 was more than what 92% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $386 · 2022: $3,002 · 2023: $2,907 · 2024: $5,183 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Consulting Fee: $8,800 · Travel and Lodging: $2,518 · Food and Beverage: $1,606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,800.00 |
| Consulting Fee | $8,800.00 |
| Travel and Lodging | $2,517.96 |
| Food and Beverage | $1,605.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $17,374.80 | 2021-2025 | Penumbra System |
| Route 92 Medical, INC. | $9,109.22 | 2024-2025 | 8f Base Camp Sheath System |
| Medtronic, INC. | $171.32 | 2021-2023 | Pipeline |
| Imperative Care, INC | $136.95 | 2021 | |
| Balt USA, LLC | $96.46 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $85.00 | 2022 | |
| Microtransponder, INC. | $64.41 | 2024-2025 | |
| Edwards Lifesciences Corporation | $20.75 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Genentech USA, INC. | $18.58 | 2023 | Ocrevus |
| Siemens Medical Solutions USA, INC. | $17.81 | 2024 | |
| Novartis Pharmaceuticals Corporation | $16.06 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brendan Eby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.